New Delhi : Pharma firm Cadila Healthcare Ltd posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.
Total income increased from Rs 2,122.61 crore for the quarter ended September 30 in the 2014-15 fiscal to Rs 2,483.19 crore in the second quarter of the current fiscal. The company has posted standalone net profit of Rs 614.08 crore for the quarter ended September. The standalone total income increased from Rs 1,396.6 crore for the year-ago quarter.
In the consolidated results, other operating income for quarter ended on September includes consideration Rs 20.03 crore received by Zydus Pharma (USA) Inc. a wholly owned subsidiary company, on sale and transfer of ownership interest in certain Abbreviated New Drug Applications for generic drug products.
